Pulse Biosciences, Inc. Financial Ratios — PLSE Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-18.9	-48.86	-71.72	-66.85	-96.78	-185.9	-217.33	- -	- -	-67.31	-74.45
Return on Assets (%)	- -	-17.45	-46.84	-67.16	-62.34	-83.46	-119.82	-133.26	-88.56	-61.61	-55.93	-64.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	-38.79	-1,606.29	- -	- -	-54
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	-4,363.05	-8,100.29	- -	- -	-21,676.57
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	-4,443.86	-8,293.86	- -	- -	-21,982.57
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2,069	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	-4,489.42	-8,357.86	- -	- -	-20,794.57
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	-4,489.42	-8,357.86	- -	- -	-20,794.57
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	-4,489.42	-8,357.86	- -	- -	-20,794.57
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-18.9	-48.86	-71.72	-66.85	-96.78	-185.9	-217.33	- -	- -	-67.31	-74.45

Credit (USD)

Credit Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	7	11	11	76	9	9	8
ST Debt	- -	- -	- -	- -	- -	- -	1	1	2	1	1	2
LT Debt	- -	- -	- -	- -	- -	7	11	10	74	8	8	6
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.14	-0.23	-0.18	-1.34	-0.22	-0.16	-0.1
Net Debt/EBITDA	- -	0.96	0.24	0.14	1.39	0.15	0.26	0.46	-0.08	1.05	2.14	1.06
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.14	-0.23	-0.18	-1.31	-0.21	-0.16	-0.1
Net Debt/EBIT	- -	0.81	0.22	0.13	1.35	0.14	0.25	0.45	-0.08	1.02	2.1	1.05
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	89.82	95.39	96.14	92.32	93.9	73.33	55.44	65.79	-2.89	74.99	86.71	85.32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	21.86	47.24	28.13	- -	18.23	6.57	7.39
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	17.94	31.57	21.39	100.59	15.11	6.09	6.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	16.03	26.19	18.51	95.21	13.67	5.69	6.3
Total Debt/Equity (%)	- -	- -	- -	- -	- -	21.86	49.6	31.52	-3,378.87	20.61	7.75	9.34
Total Debt/Capital (%)	- -	- -	- -	- -	- -	17.94	33.16	23.97	103.05	17.09	7.19	8.54
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	16.03	27.5	20.74	97.53	15.46	6.72	7.96
Net Debt to Equity	-43.6	-26.39	-8.26	-7.36	-77.04	-22.45	-54.44	-78.95	-212.54	-100.01	-102.77	-100.1
Net Debt/Capital (%)	-77.31	-35.85	-9	-7.95	-335.52	-22.58	-57.2	-153.76	38.01	-485.45	-2,062.88	-1,083.55
EBITDA	- -	-4	-9	-25	-37	-47	-49	-62	-57	-42	-55	-76
EBITDA-CapEx	- -	-4	-9	-27	-37	-47	-49	-62	-57	-42	-55	-76
Operating Income (Loss)	- -	-4	-10	-26	-38	-48	-50	-63	-58	-44	-56	-77

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	42.53	5.46	16.14	17.2	19.17	5.7	2.7	3.36	10.22	6.61	11.74	10.19
Current Ratio	42.66	6.06	16.4	17.39	19.42	5.92	2.95	4.3	10.39	6.76	11.88	10.53
Quick Ratio	42.53	5.46	16.14	17.2	19.17	5.7	2.7	3.37	10.22	6.61	11.74	10.22
CFO/Avg Current Liab	- -	-8.04	-9.61	-6.87	-8.98	-9.04	-5.87	-6.72	-6.48	-5.21	-4.34	-6.02
Common Equity/Total Assets	89.82	95.39	96.14	92.32	93.9	73.33	55.44	65.79	-2.89	74.99	86.71	85.32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	21.86	47.24	28.13	- -	18.23	6.57	7.39
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	17.94	31.57	21.39	100.59	15.11	6.09	6.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	16.03	26.19	18.51	95.21	13.67	5.69	6.3
Total Debt/Equity (%)	- -	- -	- -	- -	- -	21.86	49.6	31.52	-3,378.87	20.61	7.75	9.34
Total Debt/Capital (%)	- -	- -	- -	- -	- -	17.94	33.16	23.97	103.05	17.09	7.19	8.54
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	16.03	27.5	20.74	97.53	15.46	6.72	7.96
CFO/Total Liabilities	- -	-502.58	-792.42	-289.78	-554.95	-305.82	-192.21	-291.49	-58.67	-223.34	-206.52	-389.84
CFO/CapEx	- -	-38.57	-125.8	-4.35	-86.58	-56.23	-80.19	-123.79	-117.24	-273.07	-290.74	-161.56
Altman's Z-Score	1.09	-3.48	50.18	60.99	30.85	6.46	8.99	4.03	-6.61	17.39	34.45	31.35

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	46.49	22.95	- -	- -	2.55
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	7.85	15.9	- -	- -	142.87
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.68	4.1	- -	- -	7.93
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	540.08	88.99	- -	- -	46.05
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	3.37	2.73	- -	- -	0.3
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	108.23	133.51	- -	- -	1,203.15
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	439.7	-28.61	- -	- -	-1,014.23
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-532.23	-73.09	- -	- -	96.82
Inventories	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	88	404	240	284	620	448	105	686	1,148	931
- Cash & Cash Equivalents	7	4	2	3	51	7	12	29	61	44	118	81
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	7	11	11	76	9	9	8
Enterprise Value	-7	-4	72	366	180	265	611	430	120	651	1,039	858
Total Capital	16	14	25	46	66	37	34	47	74	54	124	88
Total Debt/Capital (%)	- -	- -	- -	- -	- -	17.94	33.16	23.97	103.05	17.09	7.19	8.54
Total Debt / EV	- -	- -	- -	- -	- -	0.03	0.02	0.03	0.63	0.01	0.01	0.01
EV/Sales	- -	- -	- -	- -	- -	- -	- -	303.38	171.01	- -	- -	2,452.1
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	73	354	199	283	564	421	96	609	1,017	925
Diluted Enterprise Value	-7	-4	71	351	148	283	563	404	110	574	908	852
EV per Share	- -	- -	5.29	21.37	8.61	12.53	23.51	14.24	3.16	11.61	15.75	12.65
TTM Sales	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -
TTM EBITDA	- -	-4	-9	-25	-37	-47	-49	-62	-57	-42	-55	-76
TTM Operating Income	- -	-4	-10	-26	-38	-48	-50	-63	-58	-44	-56	-77
TTM Cash Flow to Firm	- -	-3	-8	-11	-24	-34	-35	-54	-47	-33	-36	-54
TTM Free Cash Flow to Firm	- -	-3	-8	-9	-24	-34	-35	-54	-47	-33	-36	-54

Multiples (USD)

Valuation Multiples API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-9.11	-41.48	-8.43	-8.43	-16.15	-7.85	-2.05	-18.49	-28.07	-17.2
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-7	-4	72	366	180	265	611	430	120	651	1,039	858
Low Price	- -	- -	4.03	5.82	8.6	10.6	5.11	14.11	1.18	2.36	6.6	12.56
EV/Sales	- -	- -	- -	- -	- -	- -	- -	303.38	171.01	- -	- -	2,452.1
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-6.18	-12.84	-7.18	-6.34	-5.47	-10.06	-2.14	-6.65	-14.59	-15.4
Price/Earnings High	- -	- -	-7.96	-23.18	-11.5	-8.88	-11.86	-20.47	-9.07	-16.05	-24.73	-23.15
Price/Earnings Low	- -	- -	-4.74	-3.42	-3.98	-4.76	-2.42	-6.3	-0.7	-2.78	-7.19	-11.63
Price/Book Value	- -	- -	3.48	8.78	3.62	9.24	27.08	12.54	-46.66	15.47	9.99	11.55
Price/Book Value Average	- -	- -	2.81	8.14	4.9	9.73	13.09	19.06	-60.98	7.13	7.68	13.99
Price/Book Value High	- -	- -	3.62	14.69	7.85	13.62	28.37	38.8	-259.07	17.22	13.02	21.03
Price/Book Value Low	- -	- -	2.16	2.16	2.72	7.3	5.8	11.95	-19.88	2.98	3.79	10.56
Price/Tangible Book Value	- -	- -	5.51	10.81	4.11	12.14	38.22	15.08	-13.82	17.3	10.35	12.05
Price/Tangible Book Value Average	- -	- -	4.46	10.03	5.58	12.78	18.47	22.92	-18.06	7.98	7.96	14.59
Price/Tangible Book Value High	- -	- -	5.74	18.1	8.93	17.89	40.05	46.65	-76.73	19.25	13.49	21.94
Price/Tangible Book Value Low	- -	- -	3.42	2.67	3.09	9.59	8.19	14.37	-5.89	3.34	3.93	11.02
Price/Sales	- -	- -	- -	- -	- -	- -	- -	297.02	136.56	- -	- -	2,643.82
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	451.54	178.48	- -	- -	3,201.83
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	918.92	758.24	- -	- -	4,813.95
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	282.98	58.17	- -	- -	2,418.53
Price/Cash Flow	- -	- -	-9.04	-31.94	-8.33	-8.28	-15.95	-7.79	-2.03	-18.43	-27.98	-17.1
Price/Cash Flow Average	- -	- -	-7.31	-29.62	-11.29	-8.72	-7.71	-11.84	-2.66	-8.5	-21.51	-20.71
Price/Cash Flow High	- -	- -	-9.41	-53.46	-18.08	-12.2	-16.71	-24.09	-11.29	-20.5	-36.46	-31.13
Price/Cash Flow Low	- -	- -	-5.6	-7.88	-6.25	-6.54	-3.42	-7.42	-0.87	-3.55	-10.61	-15.64
Price/Free Cash Flow Average	- -	- -	-7.37	-38.47	-11.42	-8.87	-7.81	-11.93	-2.68	-8.53	-21.59	-20.83
Price/Free Cash Flow High	- -	- -	-9.49	-69.43	-18.29	-12.42	-16.92	-24.28	-11.39	-20.58	-36.59	-31.33
Price/Free Cash Flow Low	- -	- -	-5.65	-10.23	-6.32	-6.66	-3.46	-7.48	-0.87	-3.57	-10.64	-15.74
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	467.58	217.01	- -	- -	3,013.78
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	964.25	853.14	- -	- -	4,636.53
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	288.46	85	- -	- -	2,225.32
EV/EBITDA Average	- -	0.96	-7.83	-14.95	-7.48	-6.39	-6.11	-10.72	-2.68	-6.64	-14.04	-13.9
EV/EBITDA High	- -	0.96	-10.15	-27.09	-12.82	-8.94	-13.27	-22.1	-10.53	-17.2	-25.18	-21.39
EV/EBITDA Low	- -	0.96	-5.95	-3.88	-3.52	-4.79	-2.69	-6.61	-1.05	-2.29	-5.92	-10.27
EV/EBIT Average	- -	0.81	-7.21	-14.37	-7.22	-6.23	-5.97	-10.52	-2.62	-6.45	-13.75	-13.71
EV/EBIT High	- -	0.81	-9.35	-26.04	-12.37	-8.73	-12.98	-21.7	-10.29	-16.72	-24.65	-21.09
EV/EBIT Low	- -	0.81	-5.47	-3.73	-3.4	-4.68	-2.64	-6.49	-1.02	-2.23	-5.79	-10.12
Last Price	- -	- -	6.5	23.6	11.46	13.41	23.86	14.81	2.77	12.24	17.41	13.73
High Price	- -	- -	6.77	39.5	24.87	19.77	25	45.82	15.38	13.62	22.69	25
Enterprise Value Average	-7	-4	69	371	274	299	299	663	152	281	773	1,055
Enterprise Value High	-7	-4	90	672	470	419	648	1,367	597	729	1,387	1,623
Enterprise Value Low	-7	-4	52	96	129	224	132	409	60	97	326	779

Shares Outstanding	13	13	14	17	21	21	26	30	38	56	66	68
Diluted Weighted Avg Shares	- -	8	11	15	17	21	24	28	35	50	58	67
Basic Weighted Avg Shares	- -	8	11	15	17	21	24	28	35	50	58	67
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	0.05	0.02	- -	- -	0.01
EBITDA per Share	- -	-0.49	-0.79	-1.65	-2.11	-2.22	-2.07	-2.18	-1.64	-0.85	-0.94	-1.13
Operating Income per Share	- -	-0.58	-0.86	-1.72	-2.19	-2.27	-2.11	-2.22	-1.68	-0.88	-0.96	-1.14
Basic EPS, GAAP	- -	-0.37	-0.85	-1.7	-2.16	-2.23	-2.11	-2.24	-1.7	-0.85	-0.92	-1.08
Basic EPS from Cont Ops	- -	-0.37	-0.85	-1.7	-2.16	-2.23	-2.11	-2.24	-1.7	-0.85	-0.92	-1.08
Diluted EPS, GAAP	- -	-0.37	-0.85	-1.7	-2.16	-2.23	-2.11	-2.24	-1.7	-0.85	-0.92	-1.08
Diluted EPS from Cont Ops	- -	-0.37	-0.85	-1.7	-2.16	-2.23	-2.11	-2.24	-1.7	-0.85	-0.92	-1.08
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.43	-0.72	-0.74	-1.38	-1.62	-1.5	-1.9	-1.36	-0.66	-0.62	-0.8
Free Cash Flow per Basic Share	- -	-0.44	-0.72	-0.91	-1.39	-1.65	-1.51	-1.92	-1.37	-0.67	-0.62	-0.81
Cash & Equivalents per Share	0.55	0.28	1.21	2.23	2.85	1.2	0.79	0.95	1.61	0.79	1.79	1.19
Book Value per Share	1.26	1.07	1.87	2.69	3.17	1.45	0.88	1.18	-0.06	0.79	1.74	1.19
Tangible Book Value per Share	0.42	0.29	1.18	2.18	2.79	1.1	0.62	0.98	-0.2	0.71	1.68	1.14

Pulse Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)